|
ZNF485 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.624700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.757380E-03 |
| Normal-vs-Stage2 |
6.163800E-04 |
| Normal-vs-Stage3 |
3.642900E-03 |
| Normal-vs-Stage4 |
3.185000E-01 |
| Stage1-vs-Stage2 |
1.041760E-01 |
| Stage1-vs-Stage3 |
6.585000E-01 |
| Stage1-vs-Stage4 |
1.016600E-01 |
| Stage2-vs-Stage3 |
1.998410E-01 |
| Stage2-vs-Stage4 |
1.814490E-02 |
| Stage3-vs-Stage4 |
9.941600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.099320E-03 |
| Normal-vs-AfricanAmerican |
1.340490E-02 |
| Normal-vs-Asian |
2.439400E-01 |
| Caucasian-vs-AfricanAmerican |
3.972600E-01 |
| Caucasian-vs-Asian |
1.017950E-01 |
| AfricanAmerican-vs-Asian |
7.125500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.964920E-03 |
| Normal-vs-Female |
2.502600E-03 |
| Male-vs-Female |
3.716600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.223500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.244400E-03 |
| Normal-vs-Age(61-80Yrs) |
5.240100E-02 |
| Normal-vs-Age(81-100Yrs) |
3.390400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.781000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.416600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.137800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.150800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.139190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.872400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.986650E-01 |
| Classical-VS-Follicular |
1.280680E-03 |
| Classical-VS-Other |
6.195200E-01 |
| Classical-VS-Normal |
1.617680E-02 |
| Tall-VS-Follicular |
2.274400E-01 |
| Tall-VS-Other |
9.918400E-01 |
| Tall-VS-Normal |
8.976000E-03 |
| Follicular-VS-Other |
5.834600E-01 |
| Follicular-VS-Normal |
7.74130000000817E-05 |
| Other-VS-Normal |
2.235600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.593500E-04 |
| Normal-vs-N1 |
5.408100E-02 |
| N0-vs-N1 |
4.213800E-01 |
|
|
